Reviewed Sep 20, 2026 · maintained by Erin Rose · general reference, not legal advice
What the remit says
CO-50 — “These are non-covered services because this is not deemed a 'medical necessity' by the payer.”
Usually with: N115 “This decision was based on a Local Coverage Determination (LCD)”; N386 “This decision was based on a National Coverage Determination (NCD)”; M76 “Missing/incomplete/invalid diagnosis or condition”.
Verbatim, X12 code lists 11/1/2025.
Why it lands on drug claims
For the drugs Medicare contractors cover by article, the covered ICD-10 list is public and specific to the code — often several hundred codes for a biologic, grouped by indication. The claim needs one of them in the position the article requires (usually the primary diagnosis for the drug line). A code from the right family but the wrong specificity, a symptom code, or the indication documented but not coded is the usual cause, and that is a corrected claim, not an appeal.
When the diagnosis really is off-label, the denial is correct as filed and the appeal is a medical-necessity case: the compendia listing (CMS recognizes several for anticancer drugs, 42 CFR §414.930 and the Benefit Policy Manual chapter 15 §50.4.5), the peer-reviewed support, and the physician's statement of why this drug for this patient. That is a redetermination with records, not a resubmission.
Commercial payers publish the same lists inside their drug policies. Most also require the diagnosis to match what was on the prior authorization — a covered diagnosis that differs from the authorized one produces CO-50 with N54, and the fix is an auth amendment.
The fix
- Open the covered-diagnosis list for the drug (the Medicare hub links every article-backed drug) and find the exact code that describes the documented condition.
- If the documented indication is on the list and the claim carried a different code, correct the diagnosis pointer and resubmit as a corrected claim.
- If the indication is not on the list, do not resubmit. Build the medical-necessity appeal: physician letter, compendia citation, literature, prior therapies failed.
- For commercial claims, compare the diagnosis to the one on the authorization before anything else.
What to attach
- The pages of the LCD/article or payer policy showing the diagnosis you are relying on
- Physician documentation of the condition and the decision to treat
- For off-label: compendia listing and literature
Corrected claim or appeal?
Depends on whether the documented indication is on the payer's list. On the list but coded differently: corrected claim with the right ICD-10 and pointer. Off the list: redetermination with the physician letter, compendia and literature — never a resubmission.
Medicare windows (redetermination 120 days, reconsideration 180 days, ALJ 60 days) and the commercial path are on the denials hub, cited to 42 CFR Part 405 Subpart I; the edits are CMS's NCCI tables.
Frequently asked
- The article lists my diagnosis. Why CO-50?
- Check the pointer, not just the claim. The covered code has to be linked to the drug line (and often the administration line), and some articles require it in the primary position. A covered code sitting in position 4 with the pointer on position 1 produces exactly this denial.
- How long do I have to appeal a Medicare CO-50?
- A redetermination request must reach the MAC within 120 days of the initial determination (42 CFR §405.942). The appeal ladder on this page has the next two steps and their windows.
- Is CO-50 with N386 different?
- Yes: N386 means a National Coverage Determination, which binds every MAC and cannot be argued at the contractor level on coverage grounds. The appeal has to show the patient meets the NCD's criteria, not that the NCD is wrong.
Related references
Check the diagnosis against the policy before the claim goes out
Coverage Check reads the LCD, article or payer policy for the drug and tells you whether the ICD-10 on the order is on it — the CO-50 caught before it is filed.
Open Claim CheckSources & how this is maintained
- Computed on this page
- Nothing — this denial has no table fact; the code text is verbatim X12. Edits vintage Q3 2026.
- Authored
- How article-backed and label-covered drugs differ, the pointer trap, and the off-label appeal.
- Corrections
- Send one with the remit line.